About Precipio Diagnostics
Precipio Diagnostics is a company based in New Haven (United States) founded in 1997.. The company has 60 employees as of December 31, 2024. Precipio Diagnostics offers products and services including Molecular Kits, IV-Cell Culture Media, and Hematopathology Services. Precipio Diagnostics operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter New Haven, United States
- Employees 60 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Precipio, Inc.
-
Annual Revenue
$18.53 M21.95as on Dec 31, 2024
-
Net Profit
$-4.29 M26.7as on Dec 31, 2024
-
EBITDA
$-2.7 M55.71as on Dec 31, 2024
-
Latest Funding Round
$810.84 K (USD), Post-IPO
Oct 31, 2017
-
Investors
Enhanced Capital
& 3 more
-
Employee Count
60
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Precipio Diagnostics
Precipio Diagnostics is a publicly listed company on the NASDAQ with ticker symbol PRPO in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Precipio Diagnostics
Precipio Diagnostics offers a comprehensive portfolio of products and services, including Molecular Kits, IV-Cell Culture Media, and Hematopathology Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kits for detecting driver mutations in blood cancers
Media for multi-cell lineage culturing in diagnostics
Diagnostic testing for accurate blood cancer analysis
Unlock access to complete
Unlock access to complete
Funding Insights of Precipio Diagnostics
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $810,840
-
First Round
First Round
(02 Oct 2011)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2017 | Amount | Post-IPO - Precipio Diagnostics | Valuation |
investors |
|
| Jun, 2017 | Amount | Debt – Convertible - Precipio Diagnostics | Valuation |
investors |
|
| Jun, 2017 | Amount | Post-IPO - Precipio Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Precipio Diagnostics
Precipio Diagnostics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Enhanced Capital, Connecticut Innovations and Ironwood Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Founded Year | Domain | Location | |
|
Private equity and debt investments are focused on multiple sectors.
|
Founded Year | Domain | Location | |
|
A capital access and managed service platform is provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Precipio Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Precipio Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Precipio Diagnostics Comparisons
Competitors of Precipio Diagnostics
Precipio Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| domain | founded_year | HQ Location |
Diagnostic services are provided through laboratories and radiology units.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Precipio Diagnostics
Frequently Asked Questions about Precipio Diagnostics
When was Precipio Diagnostics founded?
Precipio Diagnostics was founded in 1997 and raised its 1st funding round 14 years after it was founded.
Where is Precipio Diagnostics located?
Precipio Diagnostics is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
How many employees does Precipio Diagnostics have?
As of Dec 31, 2024, the latest employee count at Precipio Diagnostics is 60.
What is the annual revenue of Precipio Diagnostics?
Annual revenue of Precipio Diagnostics is $18.53M as on Dec 31, 2024.
What does Precipio Diagnostics do?
Provider of cancer diagnostics and second opinion tools. The company uses ICE COLD-PCR technology to detect cancer mutations. The product includes SmartGen is a combination of diagnostic tools for the prognosis and diagnosis of cancer. SmartPath is a service that couples the patient and treating physician, with an academic expert for a second opinion. Results are generally provided within hours and customers can also request a live consultation with the pathologist. It also provides a HemeScreen Panel for screening hematologic malignancy.
Who are the top competitors of Precipio Diagnostics?
Precipio Diagnostics's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
What products or services does Precipio Diagnostics offer?
Precipio Diagnostics offers Molecular Kits, IV-Cell Culture Media, and Hematopathology Services.
Is Precipio Diagnostics publicly traded?
Yes, Precipio Diagnostics is publicly traded on NASDAQ under the ticker symbol PRPO.
Who are Precipio Diagnostics's investors?
Precipio Diagnostics has 4 investors. Key investors include Enhanced Capital, Connecticut Innovations, Ironwood Capital, and Kuzari.
What is Precipio Diagnostics's ticker symbol?
The ticker symbol of Precipio Diagnostics is PRPO on NASDAQ.